Schedule 13G ownership disclosure

ADURO BIOTECH, INC.

Security class unavailable · CUSIP: 00739L101

Event date: 2017-01-04

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
3,362,000
Percent of class
5.0000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001170316-17-000002
Form type
SC 13G
Filer
CHINOOK THERAPEUTICS, INC.
CIK
CIK 1435049
Filed
Jan 10, 2017
Reporting period
Jan 04, 2017
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub